211 related articles for article (PubMed ID: 27546217)
1. Comparison of the pharmacokinetics of vancomycin in neurosurgical and non-neurosurgical patients.
Kim AJ; Lee JY; Choi SA; Shin WG
Int J Antimicrob Agents; 2016 Oct; 48(4):381-7. PubMed ID: 27546217
[TBL] [Abstract][Full Text] [Related]
2. Development and comparison of population pharmacokinetic models of vancomycin in neurosurgical patients based on two different renal function markers.
Jing L; Liu TT; Guo Q; Chen M; Lu JJ; Lv CL
J Clin Pharm Ther; 2020 Feb; 45(1):88-96. PubMed ID: 31463971
[TBL] [Abstract][Full Text] [Related]
3. A Larger Dose of Vancomycin Is Required in Adult Neurosurgical Intensive Care Unit Patients Due to Augmented Clearance.
Lin Wu FL; Liu SS; Yang TY; Win MF; Lin SW; Huang CF; Wang KC; Shen LJ
Ther Drug Monit; 2015 Oct; 37(5):609-18. PubMed ID: 25627406
[TBL] [Abstract][Full Text] [Related]
4. Pharmacokinetics of vancomycin and dosing recommendations for trauma patients.
Medellín-Garibay SE; Ortiz-Martín B; Rueda-Naharro A; García B; Romano-Moreno S; Barcia E
J Antimicrob Chemother; 2016 Feb; 71(2):471-9. PubMed ID: 26568565
[TBL] [Abstract][Full Text] [Related]
5. Plasma and cerebrospinal fluid population pharmacokinetics of vancomycin in postoperative neurosurgical patients after combined intravenous and intraventricular administration.
Li X; Sun S; Ling X; Chen K; Wang Q; Zhao Z
Eur J Clin Pharmacol; 2017 Dec; 73(12):1599-1607. PubMed ID: 28849406
[TBL] [Abstract][Full Text] [Related]
6. Population pharmacokinetic modelling of gentamicin and vancomycin in patients with unstable renal function following cardiothoracic surgery.
Staatz CE; Byrne C; Thomson AH
Br J Clin Pharmacol; 2006 Feb; 61(2):164-76. PubMed ID: 16433871
[TBL] [Abstract][Full Text] [Related]
7. Vancomycin population pharmacokinetics and dosing recommendations in haematologic malignancy with augmented renal clearance children.
Lv CL; Lu JJ; Chen M; Zhang R; Li QC; Chen YY; Liu TT
J Clin Pharm Ther; 2020 Dec; 45(6):1278-1287. PubMed ID: 32557716
[TBL] [Abstract][Full Text] [Related]
8. The Impact of Capping Creatinine Clearance on Achieving Therapeutic Vancomycin Concentrations in Neurocritically Ill Patients with Traumatic Brain Injury.
Nelson NR; Morbitzer KA; Jordan JD; Rhoney DH
Neurocrit Care; 2019 Feb; 30(1):126-131. PubMed ID: 30051194
[TBL] [Abstract][Full Text] [Related]
9. Vancomycin pharmacokinetics in patients with severe burn injuries.
Dolton M; Xu H; Cheong E; Maitz P; Kennedy P; Gottlieb T; Buono E; McLachlan AJ
Burns; 2010 Jun; 36(4):469-76. PubMed ID: 19875238
[TBL] [Abstract][Full Text] [Related]
10. Population pharmacokinetic parameters of vancomycin in critically ill patients.
Llopis-Salvia P; Jiménez-Torres NV
J Clin Pharm Ther; 2006 Oct; 31(5):447-54. PubMed ID: 16958822
[TBL] [Abstract][Full Text] [Related]
11. [PK/PD of vancomycin in patients with severe acute pancreatitis combined with augmented renal clearance].
He J; Mao E; Jing F; Jiang H; Xu W; Yang W; Chen E
Zhonghua Wei Zhong Bing Ji Jiu Yi Xue; 2017 Sep; 29(9):810-814. PubMed ID: 28936957
[TBL] [Abstract][Full Text] [Related]
12. Are higher vancomycin doses needed in ventricle-external shunted patients?
Pujal M; Soy D; Codina C; Ribas J
Pharm World Sci; 2006 Aug; 28(4):215-21. PubMed ID: 17066239
[TBL] [Abstract][Full Text] [Related]
13. Augmented Renal Clearance Using Population-Based Pharmacokinetic Modeling in Critically Ill Pediatric Patients.
Avedissian SN; Bradley E; Zhang D; Bradley JS; Nazer LH; Tran TM; Nguyen A; Le J
Pediatr Crit Care Med; 2017 Sep; 18(9):e388-e394. PubMed ID: 28640009
[TBL] [Abstract][Full Text] [Related]
14. Vancomycin pharmacokinetics in preterm neonates and the prediction of adult clearance.
Anderson BJ; Allegaert K; Van den Anker JN; Cossey V; Holford NH
Br J Clin Pharmacol; 2007 Jan; 63(1):75-84. PubMed ID: 16869817
[TBL] [Abstract][Full Text] [Related]
15. Population Pharmacokinetics of Vancomycin in Postoperative Neurosurgical Patients and the Application in Dosing Recommendation.
Li X; Wu Y; Sun S; Zhao Z; Wang Q
J Pharm Sci; 2016 Nov; 105(11):3425-3431. PubMed ID: 27671237
[TBL] [Abstract][Full Text] [Related]
16. Pharmacokinetic/pharmacodynamic analysis of vancomycin in ICU patients.
del Mar Fernández de Gatta Garcia M; Revilla N; Calvo MV; Domínguez-Gil A; Sánchez Navarro A
Intensive Care Med; 2007 Feb; 33(2):279-85. PubMed ID: 17165021
[TBL] [Abstract][Full Text] [Related]
17. Pharmacokinetics of vancomycin in extremely obese patients with suspected or confirmed Staphylococcus aureus infections.
Adane ED; Herald M; Koura F
Pharmacotherapy; 2015 Feb; 35(2):127-39. PubMed ID: 25644478
[TBL] [Abstract][Full Text] [Related]
18. Population pharmacokinetics of intermittent vancomycin in children with cystic fibrosis.
Stockmann C; Sherwin CM; Zobell JT; Lubsch L; Young DC; Olson J; Noyes BE; Ampofo K; Spigarelli MG
Pharmacotherapy; 2013 Dec; 33(12):1288-96. PubMed ID: 23824677
[TBL] [Abstract][Full Text] [Related]
19. Pharmacokinetics and dose requirements of vancomycin in neonates.
Grimsley C; Thomson AH
Arch Dis Child Fetal Neonatal Ed; 1999 Nov; 81(3):F221-7. PubMed ID: 10525029
[TBL] [Abstract][Full Text] [Related]
20. Augmented renal clearance in septic patients and implications for vancomycin optimisation.
Baptista JP; Sousa E; Martins PJ; Pimentel JM
Int J Antimicrob Agents; 2012 May; 39(5):420-3. PubMed ID: 22386742
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
